Primary analysis of the Endrad Trial: Non-Total Body Irradiation (TBI) Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Next-Generation-Sequencing Minimal Residual Disease (NGS-MRD) Negative B-Acute Lymphoblastic Leukemia (B-ALL) of Children, Adolescents, and Young Adults (CAYA) with High-Risk/Relapsed B-ALL with Planned Comparisons to the Observational Cohort (Pediatric Transplantation and Cellular Therapy Consortium ONC1701)
Conferences
Abdel-Azim, H; Quigg, TC; Kapoor, N; Chi, Y-Y; Baregamyan, A; Higham, CS; Lehmann, L; Keating, AK; Fabrizio, VA; Skiles, JL; Shenoy, S ...
Published in: TRANSPLANTATION AND CELLULAR THERAPY
February 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
TRANSPLANTATION AND CELLULAR THERAPY
EISSN
2666-6367
ISSN
2666-6375
Publication Date
February 2026
Volume
32
Issue
2
Start / End Page
S74 / S98
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Abdel-Azim, H., Quigg, T. C., Kapoor, N., Chi, Y.-Y., Baregamyan, A., Higham, C. S., … Pulsipher, M. A. (2026). Primary analysis of the Endrad Trial: Non-Total Body Irradiation (TBI) Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Next-Generation-Sequencing Minimal Residual Disease (NGS-MRD) Negative B-Acute Lymphoblastic Leukemia (B-ALL) of Children, Adolescents, and Young Adults (CAYA) with High-Risk/Relapsed B-ALL with Planned Comparisons to the Observational Cohort (Pediatric Transplantation and Cellular Therapy Consortium ONC1701). In TRANSPLANTATION AND CELLULAR THERAPY (Vol. 32, pp. S74–S98).
Abdel-Azim, Hisham, Troy C. Quigg, Neena Kapoor, Yueh-Yun Chi, Anahit Baregamyan, Christine S. Higham, Leslie Lehmann, et al. “Primary analysis of the Endrad Trial: Non-Total Body Irradiation (TBI) Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Next-Generation-Sequencing Minimal Residual Disease (NGS-MRD) Negative B-Acute Lymphoblastic Leukemia (B-ALL) of Children, Adolescents, and Young Adults (CAYA) with High-Risk/Relapsed B-ALL with Planned Comparisons to the Observational Cohort (Pediatric Transplantation and Cellular Therapy Consortium ONC1701).” In TRANSPLANTATION AND CELLULAR THERAPY, 32:S74–98, 2026.
Abdel-Azim H, Quigg TC, Kapoor N, Chi Y-Y, Baregamyan A, Higham CS, et al. Primary analysis of the Endrad Trial: Non-Total Body Irradiation (TBI) Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Next-Generation-Sequencing Minimal Residual Disease (NGS-MRD) Negative B-Acute Lymphoblastic Leukemia (B-ALL) of Children, Adolescents, and Young Adults (CAYA) with High-Risk/Relapsed B-ALL with Planned Comparisons to the Observational Cohort (Pediatric Transplantation and Cellular Therapy Consortium ONC1701). In: TRANSPLANTATION AND CELLULAR THERAPY. 2026. p. S74–98.
Abdel-Azim, Hisham, et al. “Primary analysis of the Endrad Trial: Non-Total Body Irradiation (TBI) Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Next-Generation-Sequencing Minimal Residual Disease (NGS-MRD) Negative B-Acute Lymphoblastic Leukemia (B-ALL) of Children, Adolescents, and Young Adults (CAYA) with High-Risk/Relapsed B-ALL with Planned Comparisons to the Observational Cohort (Pediatric Transplantation and Cellular Therapy Consortium ONC1701).” TRANSPLANTATION AND CELLULAR THERAPY, vol. 32, no. 2, 2026, pp. S74–98.
Abdel-Azim H, Quigg TC, Kapoor N, Chi Y-Y, Baregamyan A, Higham CS, Lehmann L, Keating AK, Fabrizio VA, Skiles JL, Shenoy S, Milner J, Phelan R, Caywood EH, Duffner UA, Fish JD, Galvez J, Gillio A, Hanna R, Huo JS, Lalefar N, Mahadeo KM, McNerney KO, Dolan G, Salzberg D, Stefanski HE, Pulsipher MA. Primary analysis of the Endrad Trial: Non-Total Body Irradiation (TBI) Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Next-Generation-Sequencing Minimal Residual Disease (NGS-MRD) Negative B-Acute Lymphoblastic Leukemia (B-ALL) of Children, Adolescents, and Young Adults (CAYA) with High-Risk/Relapsed B-ALL with Planned Comparisons to the Observational Cohort (Pediatric Transplantation and Cellular Therapy Consortium ONC1701). TRANSPLANTATION AND CELLULAR THERAPY. 2026. p. S74–S98.
Published In
TRANSPLANTATION AND CELLULAR THERAPY
EISSN
2666-6367
ISSN
2666-6375
Publication Date
February 2026
Volume
32
Issue
2
Start / End Page
S74 / S98
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology